Pricing

Celldex Therapeutics Inc. (CLDX)

followers ·
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO: Anthony S. Marucci
Employees: 205
Web site: www.celldex.com
    Formally known as:
  • AVANT Immunotherapeutics
Stock Split History
DateRatio
2019-02-11 1:15
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available